These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 27742787)

  • 1. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
    Raue F; Frank-Raue K
    Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
    Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MicroRNAs in Thyroid Carcinoma.
    Zhu G; Xie L; Miller D
    Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
    Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
    Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Lubitz CC; Sadow PM; Daniels GH; Wirth LJ
    Thyroid; 2021 Oct; 31(10):1451-1462. PubMed ID: 33860688
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
    Vanden Borre P; Schrock AB; Anderson PM; Morris JC; Heilmann AM; Holmes O; Wang K; Johnson A; Waguespack SG; Ou SI; Khan S; Fung KM; Stephens PJ; Erlich RL; Miller VA; Ross JS; Ali SM
    Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of differentiated thyroid cancer of the follicular epithelium.
    Pacini F
    Ann Med; 2012 Nov; 44(7):651-5. PubMed ID: 21668295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin.
    Fallahi P; Ferrari SM; Elia G; Ragusa F; Patrizio A; Paparo SR; Marone G; Galdiero MR; Guglielmi G; Foddis R; Cristaudo A; Antonelli A
    Semin Cancer Biol; 2022 Feb; 79():203-216. PubMed ID: 32569821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 12. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiated thyroid gland carcinoma in children and adolescents].
    Meller J; Conrad M; Behr T; Gratz S; Becker W
    Klin Padiatr; 1998; 210(5):373-8. PubMed ID: 9782484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.
    Romei C; Elisei R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
    Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
    BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
    Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
    Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental thyroid nodules and thyroid cancer: considerations before determining management.
    Tufano RP; Noureldine SI; Angelos P
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):566-72. PubMed ID: 25928353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.
    Bauer AJ
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):589-611. PubMed ID: 33153669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
    Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
    Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.